{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T05:39:19Z","timestamp":1731649159290,"version":"3.28.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hainan Provincial Natural Science Foundation of China","award":["820QN387","820QN389"],"award-info":[{"award-number":["820QN387","820QN389"]}]},{"name":"National Natural Science Fund Cultivating 530 Project of Hainan General Hospital","award":["2021MSXM13"],"award-info":[{"award-number":["2021MSXM13"]}]},{"name":"Hainan Province Science and Technology Special Fund of China","award":["ZDKJ2021040"],"award-info":[{"award-number":["ZDKJ2021040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10193-7","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T15:15:42Z","timestamp":1731597342000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment course of cavitary pulmonary tuberculosis combined with tuberculosis in a parotid Warthin\u2019s tumor: a case report and literature review"],"prefix":"10.1186","volume":"24","author":[{"given":"Sha-Sha","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Nian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"12","key":"10193_CR1","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s00405-020-06081-w","volume":"277","author":"O Tun\u00e7","year":"2020","unstructured":"Tun\u00e7 O, et al. Change in Warthin\u2019s tumor incidence: a 20-year joinpoint trend analysis. Eur Arch Otorhinolaryngol. 2020;277(12):3431\u20134.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"10","key":"10193_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4103\/1947-2714.120801","volume":"5","author":"M Ulusan","year":"2013","unstructured":"Ulusan M, Abul Y, Bak\u0131r S. Mycobacterium Tuberculosis infection within a Warthin Tumor: a Case Report and Literature Review. N Am J Med Sci. 2013;5(10):617\u20139.","journal-title":"N Am J Med Sci"},{"key":"10193_CR3","doi-asserted-by":"crossref","unstructured":"Quer M et al. Current trends and controversies in the management of Warthin Tumor of the parotid gland. Diagnostics (Basel), 2021. 11(8).","DOI":"10.3390\/diagnostics11081467"},{"issue":"10181","key":"10193_CR4","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin J, Cox H, Pai M. Tuberculosis Lancet. 2019;393(10181):1642\u201356.","journal-title":"Tuberculosis Lancet"},{"key":"10193_CR5","doi-asserted-by":"crossref","unstructured":"Cata\u00f1o JC, Robledo J. Tuberculous lymphadenitis and Parotitis. Microbiol Spectr, 2016. 4(6).","DOI":"10.1128\/microbiolspec.TNMI7-0008-2016"},{"issue":"6","key":"10193_CR6","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1097\/SCS.0b013e31818ac146","volume":"19","author":"C Ozcan","year":"2008","unstructured":"Ozcan C, et al. Mycobacterium tuberculosis infection within parotid gland Warthin tumor. J Craniofac Surg. 2008;19(6):1561\u20135.","journal-title":"J Craniofac Surg"},{"issue":"4","key":"10193_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000325346","volume":"53","author":"CJ Cobb","year":"2009","unstructured":"Cobb CJ, Greaves TS, Raza AS. Fine needle aspiration cytology and diagnostic pitfalls in Warthin\u2019s tumor with necrotizing granulomatous inflammation and facial nerve paralysis: a case report. Acta Cytol. 2009;53(4):431\u20134.","journal-title":"Acta Cytol"},{"key":"10193_CR8","doi-asserted-by":"crossref","unstructured":"Maheshwari V et al. Warthin\u2019s tumour with coexistent tuberculosis. BMJ Case Rep, 2011. 2011.","DOI":"10.1136\/bcr.09.2010.3349"},{"issue":"5","key":"10193_CR9","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1177\/014556131209100514","volume":"91","author":"KC Wu","year":"2012","unstructured":"Wu KC, Chen BN. Mycobacterial tuberculosis superimposed on a Warthin tumor. Ear Nose Throat J. 2012;91(5):E4\u20136.","journal-title":"Ear Nose Throat J"},{"issue":"2","key":"10193_CR10","first-page":"85","volume":"78","author":"NL Aaronson","year":"2014","unstructured":"Aaronson NL, Adam SI, Boey HP. Warthin\u2019s tumor with superimposed mycobacterium tuberculosis infection. Conn Med. 2014;78(2):85\u20139.","journal-title":"Conn Med"},{"issue":"7","key":"10193_CR11","doi-asserted-by":"publisher","first-page":"e18763","DOI":"10.1097\/MD.0000000000018763","volume":"99","author":"SL Chen","year":"2020","unstructured":"Chen SL, et al. Warthin\u2019s tumor with necrotizing tuberculous granulomatous inflammation causing severe facial nerve adhesion in parotid gland: a case report and literature review. Med (Baltim). 2020;99(7):e18763.","journal-title":"Med (Baltim)"},{"key":"10193_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3348\/jksr.2011.65.3.213","volume":"65","author":"H Lee","year":"2011","unstructured":"Lee H, Suh S. Tuberculosis infection within a Warthin\u2019s Tumor of the parotid gland: a Case Report. J Korean Soc Radiol. 2011;65:213.","journal-title":"J Korean Soc Radiol"},{"issue":"4","key":"10193_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1016-3190(08)60061-0","volume":"20","author":"Y-H Wen","year":"2008","unstructured":"Wen Y-H, Chen P-R, Wu H-P. Tuberculosis infection within a Warthin\u2019s Tumor of the parotid gland. Tzu Chi Med J. 2008;20(4):332\u20134.","journal-title":"Tzu Chi Med J"},{"issue":"10","key":"10193_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1046\/j.1440-1827.2001.01281.x","volume":"51","author":"M Watanabe","year":"2001","unstructured":"Watanabe M, et al. Mycobacterium tuberculosis infection within Warthin\u2019s tumor: report of two cases. Pathol Int. 2001;51(10):797\u2013801.","journal-title":"Pathol Int"},{"issue":"3","key":"10193_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0190-9622(99)70499-8","volume":"40","author":"JW Patterson","year":"1999","unstructured":"Patterson JW, Wright ED, Camden S. Extraparotid Warthin\u2019s tumor. J Am Acad Dermatol. 1999;40(3):468\u201370.","journal-title":"J Am Acad Dermatol"},{"key":"10193_CR16","unstructured":"Thompson AS, Bryant HC Jr. Histogenesis of papillary cystadenoma lymphomatosum (Warthin\u2019s tumor) of the parotid salivary gland. Am J Pathol. 1950;26(5):807\u201349."},{"issue":"3","key":"10193_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0901-5027(89)80108-0","volume":"18","author":"N Segami","year":"1989","unstructured":"Segami N, Fukuda M, Manabe T. Immunohistological study of the epithelial components of Warthin\u2019s tumor. Int J Oral Maxillofac Surg. 1989;18(3):133\u20137.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"10193_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.amjoto.2004.08.009","volume":"26","author":"E Daniel","year":"2005","unstructured":"Daniel E, Sr. McGuirt WF. Neck masses secondary to heterotopic salivary gland tissue: a 25-year experience. Am J Otolaryngol. 2005;26(2):96\u2013100.","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"10193_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jcms.2014.11.019","volume":"43","author":"GD Orabona","year":"2015","unstructured":"Orabona GD, et al. Warthin\u2019s tumour: aetiopathogenesis dilemma, ten years of our experience. J Craniomaxillofac Surg. 2015;43(4):427\u201331.","journal-title":"J Craniomaxillofac Surg"},{"issue":"9","key":"10193_CR20","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/aje\/kwp244","volume":"170","author":"LS Freedman","year":"2009","unstructured":"Freedman LS, Oberman B, Sadetzki S. Using time-dependent covariate analysis to elucidate the relation of smoking history to Warthin\u2019s tumor risk. Am J Epidemiol. 2009;170(9):1178\u201385.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10193_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12105-019-01049-7","volume":"14","author":"DJ Zaccarini","year":"2020","unstructured":"Zaccarini DJ, Khurana KK. Incidence of Non-salivary Gland neoplasms in patients with Warthin Tumor: a study of 73 cases. Head Neck Pathol. 2020;14(2):412\u20138.","journal-title":"Head Neck Pathol"},{"issue":"3","key":"10193_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH634>3.0.CO;2-U","volume":"191","author":"PD Lewis","year":"2000","unstructured":"Lewis PD, et al. Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin\u2019s tumour. J Pathol. 2000;191(3):274\u201381.","journal-title":"J Pathol"},{"key":"10193_CR23","doi-asserted-by":"crossref","unstructured":"Mandic R et al. Aberrant expression of glyceraldehyde-3-Phosphate dehydrogenase (GAPDH) in Warthin Tumors. Cancers (Basel), 2020. 12(5).","DOI":"10.3390\/cancers12051112"},{"issue":"7","key":"10193_CR24","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1148\/rg.2019190109","volume":"39","author":"SY Rodriguez-Takeuchi","year":"2019","unstructured":"Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary Tuberculosis: pathophysiology and imaging findings. Radiographics. 2019;39(7):2023\u201337.","journal-title":"Radiographics"},{"issue":"10","key":"10193_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1017\/S0022215107006913","volume":"121","author":"KC Prasad","year":"2007","unstructured":"Prasad KC, et al. Tuberculosis in the head and neck: experience in India. J Laryngol Otol. 2007;121(10):979\u201385.","journal-title":"J Laryngol Otol"},{"issue":"8","key":"10193_CR26","doi-asserted-by":"publisher","first-page":"e1008632","DOI":"10.1371\/journal.ppat.1008632","volume":"16","author":"SKC Ganchua","year":"2020","unstructured":"Ganchua SKC, et al. Lymph Nodes-the neglected battlefield in tuberculosis. PLoS Pathog. 2020;16(8):e1008632.","journal-title":"PLoS Pathog"},{"issue":"11","key":"10193_CR27","doi-asserted-by":"publisher","first-page":"e1007337","DOI":"10.1371\/journal.ppat.1007337","volume":"14","author":"SKC Ganchua","year":"2018","unstructured":"Ganchua SKC, et al. Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques. PLoS Pathog. 2018;14(11):e1007337.","journal-title":"PLoS Pathog"},{"issue":"10","key":"10193_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/nm.4161","volume":"22","author":"H Esmail","year":"2016","unstructured":"Esmail H, et al. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission and computed tomography. Nat Med. 2016;22(10):1090\u20133.","journal-title":"Nat Med"},{"key":"10193_CR29","doi-asserted-by":"crossref","unstructured":"Alsayed SSR, Gunosewoyo H. Tuberculosis: Pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci, 2023. 24(6).","DOI":"10.3390\/ijms24065202"},{"issue":"7","key":"10193_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/qjmed\/hcz266","volume":"113","author":"N Gupta","year":"2020","unstructured":"Gupta N, et al. Parotid gland tuberculosis. QJM. 2020;113(7):500\u20131.","journal-title":"QJM"},{"issue":"8","key":"10193_CR31","first-page":"e27590","volume":"14","author":"M Bakir","year":"2022","unstructured":"Bakir M, et al. Parotid gland tuberculosis: a Case Report and Literature Review. Cureus. 2022;14(8):e27590.","journal-title":"Cureus"},{"issue":"6","key":"10193_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/000992288602500607","volume":"25","author":"C Myer","year":"1986","unstructured":"Myer C, Cotton RT. Salivary gland disease in children: a review. Part 1: acquired non-neoplastic disease. Clin Pediatr (Phila). 1986;25(6):314\u201322.","journal-title":"Clin Pediatr (Phila)"},{"issue":"5","key":"10193_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s15010-019-01322-5","volume":"47","author":"W Oglesby","year":"2019","unstructured":"Oglesby W, et al. Metformin in Tuberculosis: beyond control of hyperglycemia. Infection. 2019;47(5):697\u2013702.","journal-title":"Infection"},{"issue":"5","key":"10193_CR34","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.21037\/jtd.2018.05.11","volume":"10","author":"A Esmail","year":"2018","unstructured":"Esmail A, et al. Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill. J Thorac Dis. 2018;10(5):3102\u201318.","journal-title":"J Thorac Dis"},{"issue":"6","key":"10193_CR35","first-page":"288","volume":"157","author":"V Antonio-Arques","year":"2021","unstructured":"Antonio-Arques V, Franch-Nadal J, Cayl\u00e0 JA. Diabetes and tuberculosis: a syndemic complicated by COVID-19. Med Clin (Engl Ed). 2021;157(6):288\u201393.","journal-title":"Med Clin (Engl Ed)"},{"key":"10193_CR36","doi-asserted-by":"crossref","unstructured":"van Crevel R, Critchley JA. The Interaction of Diabetes and Tuberculosis: translating Research to Policy and Practice. Trop Med Infect Dis, 2021. 6(1).","DOI":"10.3390\/tropicalmed6010008"},{"key":"10193_CR37","first-page":"204993612210958","volume":"9","author":"G C\u00e1ceres","year":"2022","unstructured":"C\u00e1ceres G, Calderon R, Ugarte-Gil C. Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression. Ther Adv Infect Dis. 2022;9:20499361221095831.","journal-title":"Ther Adv Infect Dis"},{"key":"10193_CR38","unstructured":"[Expert consensus on diagnosis and treatment of elderly pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi, 2023. 46(11): pp. 1068\u20131084."},{"key":"10193_CR39","doi-asserted-by":"publisher","first-page":"1250001","DOI":"10.3389\/fendo.2023.1250001","volume":"14","author":"F Meng","year":"2023","unstructured":"Meng F, et al. Impact of diabetes itself and glycemic control status on tuberculosis. Front Endocrinol (Lausanne). 2023;14:1250001.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10193_CR40","doi-asserted-by":"crossref","unstructured":"Grace AG et al. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis. Cochrane Database Syst Rev, 2019. 12(12): p. Cd012918.","DOI":"10.1002\/14651858.CD012918.pub2"},{"issue":"3","key":"10193_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1440-1843.2010.01738.x","volume":"15","author":"CY Chiang","year":"2010","unstructured":"Chiang CY, Centis R, Migliori GB. Drug-resistant tuberculosis: past, present, future. Respirology. 2010;15(3):413\u201332.","journal-title":"Respirology"},{"issue":"5","key":"10193_CR42","doi-asserted-by":"publisher","first-page":"a017822","DOI":"10.1101\/cshperspect.a017822","volume":"5","author":"G Sotgiu","year":"2015","unstructured":"Sotgiu G, et al. Tuberculosis treatment and drug regimens. Cold Spring Harb Perspect Med. 2015;5(5):a017822.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"10193_CR43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","volume":"167","author":"D Yee","year":"2003","unstructured":"Yee D, et al. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167(11):1472\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"10193_CR44","doi-asserted-by":"publisher","first-page":"954074","DOI":"10.3389\/fcimb.2022.954074","volume":"12","author":"C Nimmo","year":"2022","unstructured":"Nimmo C, et al. Evolution of Mycobacterium tuberculosis drug resistance in the genomic era. Front Cell Infect Microbiol. 2022;12:954074.","journal-title":"Front Cell Infect Microbiol"},{"key":"10193_CR45","doi-asserted-by":"crossref","unstructured":"Goossens SN, Sampson SL, Van Rie A. Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev, 2020. 34(1).","DOI":"10.1128\/CMR.00141-20"},{"key":"10193_CR46","unstructured":"WHO. 2023. Global tuberculosis report 2023. WHO, Geneva, Switzerland. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023"},{"issue":"35","key":"10193_CR47","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.1073\/pnas.1121497109","volume":"109","author":"PL Lin","year":"2012","unstructured":"Lin PL, et al. Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. Proc Natl Acad Sci U S A. 2012;109(35):14188\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10193_CR48","unstructured":"Kislitsyna NA. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients]. Probl Tuberk, 1985(4): pp. 55\u20137."},{"issue":"2","key":"10193_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/157488410791110797","volume":"5","author":"V Dartois","year":"2010","unstructured":"Dartois V, Barry CE. Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis. Curr Clin Pharmacol. 2010;5(2):96\u2013114.","journal-title":"Curr Clin Pharmacol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10193-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:03:35Z","timestamp":1731600215000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10193-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10193"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10193-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written and informed consent to publish was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1298"}}